SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-10-091996
Filing Date
2010-10-07
Accepted
2010-10-07 13:24:15
Documents
2
Group Members
ANSBERT GADICKEDENNIS HENNERKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLCMPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES III GP LPMPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND LPMPM BIOVENTUR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A f57027sc13dza.htm SC 13D/A 274087
2 EX-99.A f57027exv99wa.htm EX-99.A 32591
  Complete submission text file 0000950123-10-091996.txt   309387
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200
MPM BIOVENTURES III L.P. (Filed by) CIK: 0001173408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 (510) 585-2200
ARYx Therapeutics, Inc. (Subject) CIK: 0001410064 (see all company filings)

IRS No.: 770456039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83705 | Film No.: 101113461
SIC: 2834 Pharmaceutical Preparations